EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E–Mutant NSCLC Cell Lines
- DOI
- 10.1158/1535-7163.mct-15-0375
- Published
- 2016-07-01
- Container
- Molecular Cancer Therapeutics
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/1535-7163.mct-15-0375,
title = {EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E–Mutant NSCLC Cell Lines},
author = {Sung-Moo Kim and Hwan Kim and Kang Won Jang and Min Hwan Kim and Jinyoung Sohn and Mi Ran Yun and Han Na Kang and Chan Woo Kang and Hye Ryun Kim and Sun Min Lim and Yong Wha Moon and Joo Hang Kim and Soonmyung Paik and Byoung Chul Cho},
year = {2016},
journal = {Molecular Cancer Therapeutics},
doi = {10.1158/1535-7163.mct-15-0375},
url = {https://doi.org/10.1158/1535-7163.mct-15-0375}
}RIS
TY - JOUR TI - EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E–Mutant NSCLC Cell Lines AU - Sung-Moo Kim AU - Hwan Kim AU - Kang Won Jang AU - Min Hwan Kim AU - Jinyoung Sohn AU - Mi Ran Yun AU - Han Na Kang AU - Chan Woo Kang AU - Hye Ryun Kim AU - Sun Min Lim AU - Yong Wha Moon AU - Joo Hang Kim AU - Soonmyung Paik AU - Byoung Chul Cho PY - 2016 JO - Molecular Cancer Therapeutics DO - 10.1158/1535-7163.mct-15-0375 UR - https://doi.org/10.1158/1535-7163.mct-15-0375 ER -
APA
Kim, S., Kim, H., Jang, K. W., Kim, M. H., Sohn, J., Yun, M. R., Kang, H. N., Kang, C. W., Kim, H. R., Lim, S. M., Moon, Y. W., Kim, J. H., Paik, S., & Cho, B. C. (2016). EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E–Mutant NSCLC Cell Lines. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-15-0375
Source records
- crossref · retrieved 2026-09-27T01:37:24.250Z